Twist Bioscience Corp
TWST- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001581280
In the last 90 days, Twist Bioscience Corp insiders filed 0 open-market purchases and 34 sales; 339 institutions reported holding it in 13F filings for Q2 2026, worth $7.85B in total; ARK Invest is the only superinvestor holding it.
Key figures
- Market capClose on Nov 10, 2026
- $8.29B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $102.6M in total
- 34
- 13F holdersQ2 2026, +61 vs. previous quarter
- 339
- 13F valueReported value at the end of Q2 2026
- $7.85B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $376.6M
- +20.3% year over year
- Net income, FY2025
- -$77.7M
- No comparable prior period
- Free cash flow, FY2025
- -$75.6M
- No comparable prior period
- Revenue, Q3 FY2026
- $118.4M
- +23.2% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $77.7M (20.6% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 9.84M
- Shares sold short
- Change
- −371.7K
- −3.6% vs. previous
- Days to cover
- 4.35
- At average daily volume
Superinvestors holding TWST, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Twist Bioscience Corp on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Twist Bioscience Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Cho DennisSee Remarks | SSale | −949 | $135.40 | −$128.5K | −1.5%62.8K after | |
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Finn Patrick JohnPresident and COO | SSale | −2.56K | $135.40 | −$347.3K | −1.4%180.3K after | |
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Leproust Emily M.Chief Executive Officer | SSale | −4.57K | $135.40 | −$619.2K | −0.8%558.2K after | |
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −148 | $135.40 | −$20.0K | −0.3%42.8K after | |
| Nov 5, 2026 (view filing)4:05 PM ET | Nov 3 | 2 days | Green PaulaSVP of Human Resources | SSale | −1.01K | $135.40 | −$136.3K | −0.9%105.6K after | |
| Oct 27, 2026 (view filing)4:05 PM ET | Oct 23 | 4 days | Finn Patrick JohnPresident and COO | SSale | −2.25K | $134.59 | −$302.2K | −1.2%182.8K after | |
| Oct 13, 2026 (view filing)4:05 PM ET | Oct 9 | 4 days | Laponis AdamChief Financial Officer | SSale | −2.46K | $156.30 | −$384.8K | −2.4%98.1K after | |
| Oct 7, 2026 (view filing)4:05 PM ET | Oct 5 | 2 days | Leproust Emily M.Chief Executive Officer | SSale | −4.55K | $202.15 | −$919.4K | −0.8%562.8K after | 8 lots10b5-1 |
| Oct 5, 2026 (view filing)4:05 PM ET | Oct 2 | 3 days | Laponis AdamChief Financial Officer | SSale | −8.06K | $188.88 | −$1.52M | −7.4%100.6K after | |
| Oct 5, 2026 (view filing)4:05 PM ET | Oct 2 | 3 days | Green PaulaSVP of Human Resources | SSale | −10.1K | $188.88 | −$1.91M | −8.6%106.6K after |
Top 10 13F holders, Q2 2026
See all 339 holdersThe largest institutional positions in Twist Bioscience Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,833,891 | $600.2M | 0.01% | +279,529+5.0% | Added |
| Artisan Partners Limited Partnership | 4,802,017 | $494.0M | 0.81% | −1,565,760−24.6% | Reduced |
| FMR LLC | 4,703,044 | $483.8M | 0.02% | +2,813,099+148.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 4,549,803 | $468.1M | 3.04% | −1,792,930−28.3% | Reduced |
| Price T Rowe Associates Inc | 3,634,652 | $373.9M | 0.04% | +3,564,347+5,069.8% | Added |
| State Street Corp | 3,232,532 | $332.6M | 0.01% | −438,150−11.9% | Reduced |
| Vanguard Portfolio Management LLC | 2,824,989 | $290.6M | 0.01% | +175,888+6.6% | Added |
| Vanguard Capital Management LLC | 2,699,280 | $277.7M | 0.01% | +60,236+2.3% | Added |
| EdgePoint Investment Group Inc. | 2,521,635 | $259.4M | 1.96% | −2,860,886−53.2% | Reduced |
| William Blair Investment Management, LLC | 2,174,594 | $223.7M | 0.67% | −3,095,124−58.7% | Reduced |
Holders of 5% or more of TWST
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Twist Bioscience Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 14.40%9.54M shares | +1.20 ppfrom 13.20% | Mar 10, 20227 filings | Nov 5, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 8.30%4.93M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Artisan Partners Limited Partnership | 13G/A | 7.70%4.80M shares | −2.40 ppfrom 10.10% | Feb 12, 20247 filings | Aug 13, 2026 | SEC |
| Price T Rowe Associates Inc | 13G | 5.80%3.63M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| ARK Investment Management LLCSuperinvestorARK Invest | 13G/A | 5.11%3.39M shares | −2.20 ppfrom 7.31% | Jan 11, 202111 filings | Sep 8, 2026 | SEC |
Politician trades
All politician trades in TWST1 member of Congress reported 2 trades in Twist Bioscience Corp since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Apr 25, 2022 |  Dwight Evans House · PA | Sell | $1K-$15K |
| Apr 23, 2020 | Dwight Evans House · PA | Buy | $1K-$15K |
House · PA · Apr 25, 2022
Sell$1K-$15K
House · PA · Apr 23, 2020
Buy$1K-$15K